| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.37 |
3e-19 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.46 |
9e-19 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.36 |
2e-18 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
7e-13 |
| mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-06 |
| mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-05 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-05 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
3e-05 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0001 |